Empowering development and enabling seamless assay transfer

Exploratory and preclinical studies often require rapid development of assays to inform key development decisions. Working in a flexible environment is key to creating novel immunoassays or providing cellular-based analysis, but researchers must also think ahead to proactively plan for a transition to CAP/CLIA or GxP facility for qualification, method validation and implementation to support the requirements of a clinical trial. These case studies showcase a number of challenging, high-profile projects supported by the Labcorp Translational Biomarker Solutions (Labcorp TBS) team.